Optimizing Kitting For Cell Therapy Trials In Pediatric Oncology

In a Phase I multicenter pediatric cell therapy trial targeting relapsed or refractory solid tumors, the stakes were incredibly high. The success of manufacturing the autologous therapy hinged on the collection of viable, sterile tumor tissue at precise moments and under stringent conditions. Without this critical step, the entire process would be compromised.

Precision for Medicine’s Kitting team rose to the occasion, playing a crucial role in overcoming this challenge. They meticulously designed and delivered custom kits that ensured the sterility and compliance of the samples. These kits were essential for the successful transfer of tumor tissue to the manufacturing site, enabling the production of the autologous therapy. Their efforts were instrumental in maintaining the integrity of the samples and ensuring the trial's progress.